Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs UnitedHealth Group Inc (UNH) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs UnitedHealth Group Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while UnitedHealth Group Inc trades at $396.94 (market cap $339.08B). The key difference: UnitedHealth Group Inc is far larger — about 10.9× GE HealthCare Technologies Inc. Common Stock's market cap, and UnitedHealth Group Inc pays the higher dividend (2.46%). Which is the better fit depends on your goals.

GEHCUNH
Market Cap
$31.07B$339.08B
Volume
3,443,02012,648,635
Sector
HealthHealth
52-Week High
$88.16$436.35
52-Week Low
$59.48$259.02
Enterprise Value
$39.53B$380.94B
Dividend Yield
0.23%2.46%
Typical Hold Time
—98 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $378.52, down 0.21% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats in recent quarters, including Q3 2026 EPS of $4.69 beating expectations of $4.14. Revenue growth remains solid at $447.57B for 2025, though net margins have compressed to 3.14%. Recent developments include strategic moves with TPG for WellMed operations and continued AI investments in Optum Insight.

UNH presents a compelling investment case with 82.7% analyst buy ratings and a $470.11 consensus price target representing 24% upside. The company's Medicare Advantage strength and Optum improvements support growth, though regulatory scrutiny and medical cost pressures remain key risks. Strong institutional ownership and Michael Burry's recent call option position signal confidence in the turnaround story.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEHC

No sentiment data available yet.

UNH
30% Buy70% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →